Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zhejiang Chemsyn Pharm CoBJSE:920656 36 Days Payable is 40.24 as of Mar. 2026, which is 4% above its 10-year median of 38.71. GuruFocus rates BJSE:920656 with a GF Score™ of 36/100. The stock has 4 warning signs investors should review. Among 13 Healthcare Plans companies, Zhejiang Chemsyn Pharm Co ranks worse than 61.54% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BJSE:920656 vs UNH, CVS, ELV: Days Payable Comparison
For the Healthcare Plans subindustry, Zhejiang Chemsyn Pharm Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Chemsyn Pharm Co Days Payable vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Zhejiang Chemsyn Pharm Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Zhejiang Chemsyn Pharm Co's Days Payable falls into.
Zhejiang Chemsyn Pharm Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Zhejiang Chemsyn Pharm Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Chemsyn Pharm Co (BJSE:920656) has a Days Payable of 40.24 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Zhejiang Chemsyn Pharm Co and its competitors. This is near median its historical median of 38.71. Over the past decade, Zhejiang Chemsyn Pharm Co's Days Payable has ranged from 21.21 to 64.25. According to the industry distribution chart, Zhejiang Chemsyn Pharm Co ranks #8 out of 13 companies in the Healthcare Plans industry, placing it in the top 61.5%.
Is Zhejiang Chemsyn Pharm Co's Days Payable too high?
Zhejiang Chemsyn Pharm Co's current Days Payable of 40.24 is near median its 10-year median of 38.71. Over the past 10 years, this metric has ranged from a low of 21.21 to a high of 64.25. The Healthcare Plans industry median Days Payable is 38.89. Zhejiang Chemsyn Pharm Co's value of 40.24 is 3.5% above this industry median. Based on the distribution chart, Zhejiang Chemsyn Pharm Co ranks #8 out of 13 companies in the Healthcare Plans industry, which is below the industry midpoint. Overall, Zhejiang Chemsyn Pharm Co has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Chemsyn Pharm Co's Days Payable compare to UNH and CVS?
According to the Healthcare Plans industry distribution chart, Zhejiang Chemsyn Pharm Co ranks #8 out of 13 companies for Days Payable. This places Zhejiang Chemsyn Pharm Co in the lower half of its industry. The industry median Days Payable is 38.89. Zhejiang Chemsyn Pharm Co's value of 40.24 is 3.5% above this benchmark. Historically, Zhejiang Chemsyn Pharm Co's own Days Payable has ranged from 21.21 to 64.25 over the past decade. While the company's 10-year median is 38.71 vs. the industry median of 38.89, Zhejiang Chemsyn Pharm Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Plans company?
The median Days Payable among Healthcare Plans companies is 38.89, based on 13 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhejiang Chemsyn Pharm Co's current Days Payable of 40.24 is 3.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Zhejiang Chemsyn Pharm Co and its competitors. For the Healthcare Plans industry, the median Days Payable is 38.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Chemsyn Pharm Co's current Days Payable is 40.24, which is near median its own 10-year median of 38.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Chemsyn Pharm Co stock overvalued right now?
Zhejiang Chemsyn Pharm Co (BJSE:920656) has a current Days Payable of 40.24. The current Days Payable is 40.24, which is near median its 10-year median of 38.71 and 3.5% above the Healthcare Plans industry median of 38.89. Zhejiang Chemsyn Pharm Co's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Zhejiang Chemsyn Pharm Co (BJSE:920656), the current Days Payable is 40.24 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Zhejiang Chemsyn Pharm Co Ltd is engaged in Research, development, production and sales of veterinary drug raw materials, pharmaceutical raw materials and intermediates.
36GF Score
Get the complete analysis for BJSE:920656
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920656 has been successfully added to your 
